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Abstract 
We detected telomerase activity in human lymphocytes obtained from normal donors. Telomerase was up-regulated 
within 24 h when peripheral blood mononuclear cells were cultured in the presence of phytohemagglutinin. The activity 
increased gradually over 72 h, then remained stable for 96 h. During this period, cell number and the length of telomeric 
DNA remained constant. Anti-CD3 monoclonal antibody and Pansolbin also induced telomerase activity. These results 
demonstrate that telomerase is regulated during lymphocyte activation as cells progress from G O to S phase. This system is 
useful for the study of telomerase during carcinogenesis, and in the testing of telomerase-inhibitory d ugs. 
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1. Introduction 
Telomeres are the physical ends of eukaryotic 
chromosomes [1]. The telomeric DNA sequence is 
highly conserved among all well-characterized u- 
karyotic nuclear chromosomes and is quite different 
from the termini of linear viral, extranuclear plasmid, 
or mitochondrial DNA [2]. Human telomeric DNA 
comprises 2-15 kb of the tandemly repeated se- 
quence, (TTAGGG)n, oriented 5'-3' toward the end 
of the chromosome. The evolutionary conservation of
this repetitive DNA sequence implies that the se- 
quence is essential to cellular function [3]. Telomere 
replication involves the de novo addition of tandem 
telomeric repeats onto chromosome ends by the en- 
zyme telomerase. It has been proposed that telom- 
erase is repressed in somatic tissues, and that telom- 
eres become shorter during somatic development, and 
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with the increasing age of the individual. Resting 
normal lymphocytes can not be maintained in the 
absence of growth factors and eventually succumb to 
apoptosis. Given the ability of lymphokine activated 
killer (LAK) cells to proliferate for long periods in 
the presence of interleukin-2 (IL-2) [4], we speculated 
that the activation of telomerase by IL-2 may occur 
in LAK cells, allowing the cells to proliferate [5,6] by 
stabilizing telomere length through the addition of 
telomeric repeats. To investigate this hypothesis, we 
measured telomere length and telomerase activity 
during the proliferation of human lymphocytes. 
2. Materials and methods 
2.1. Cells 
Peripheral blood mononuclear cells (PBMCs) from 
four healthy volunteers were isolated by Ficoll-Con- 
ray density gradient centrifugation after obtaining 
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informed consent. For some experiments normal 
polymorphonuclear leukocytes, monocytes, T cells, 
and B cells were isolated[ from three of the normal 
individuals, according to a method already described 
[7]. 
2.2. Cell stimulation 
PBMCs were washed twice and suspended in RPMI 
1640 medium containing 10% fetal calf serum, 100 
U/ml  recombinant IL-2 (Shionogi Pharmaceutical 
Co., Osaka, Japan) 2 mmol/ l  L-glutamine, 100 U /ml  
penicillin and 10 mg/ml  streptomycin the pres- 
ence of a 1:2000 final concentration f phytohemag- 
glutinin-P (PHA-P) (Difi:o Laboratories, Grand Is- 
land, NY). These final concentrations of IL-2 and 
PHA-P were selected because in preliminary experi- 
ments the highest level of proliferative response, as 
determined by the incoqmration of [3H] thymidine 
into cells, was obtained at these concentrations. Ini- 
tially, 1 × 10 6 PBMCs were cultured in 24-well tis- 
sue culture plates (Linbro Division, Flow Laborato- 
ries, Hamden, CT) in 2 ml of the above complete 
medium at 37°C in humidified air containing 5% 
CO 2. The number of cells was counted every day 
with a hematocytometer under a microscope. PBMCs 
also were cultured in the presence of an anti-CD3 
monoclonal antibody (mAb) (OKT3; provided by Dr. 
G. Goldstein), lipopolysaccharide (LPS) (Difco) or 
Staphylococcus aureus Cowan I strain organisms 
(SAC) (Pansolbin; Difco). In some experiments, cy- 
cloheximide (CHX) (Sigma Chemical Co., St Louis, 
MO) was added 1 h prior to cell stimulation, at a 
final concentration 10btg/ml. The cells were col- 
lected daily for 2 to 4 days, washed once, and used 
for DNA analysis and the telomerase assay. 
2.3. Telomerase assay 
Cells were suspended in ice-cold washing buffer 
[10 mM Hepes-KOH (pH 7.5), 1.5 mM MgC12, 10 
mM KC1, and 1 mM DTT], pelletted again, and 
resuspended (10 S cells/20/,d) in ice-cold lysis buffer 
[10 mM Tris-HC1 (pH 7.5), 1 mM MgC12, 1 mM 
EDTA, 0.1 mM PMSF, 5 mM /3-mercaptoethanol, 
0.5% Chaps, and 10% glycerol]. The suspension was 
incubated for 30 min on ice and then centrifuged at 
100000 × g for 30 min at 4°C. The supernatant was 
removed, quick-frozen in liquid nitrogen, and stored 
at -80°C. The protein concentration was determined 
by the Bradford assay (Bio-Rad). Telomerase activity 
was assayed by the TRAP method in a total volume 
of 50 /zl [8]. In brief, aliquots of untreated cell 
extracts or extracts treated with RNase (at a final 
concentration f 0.2 mg/ml  for 10 min at 25°C) were 
incubated with 0.1 /zg of TS oligonucleotide (5'- 
AATCCGTCGAGCAGAGTT-3') for 15 min at 20°C 
in the following reaction mixture: 20 mM Tris-HC1 
(pH 8.3), 1.5 mM MgC12, 63 mM KC1, 0.005% 
Tween-20, 1 mM EDTA, 50 /.~M dNTPs, 1 /zg of 
T4g32 protein (Boehringer-Mannheim, Mannheim, 
Germany), 0.1 mg/ml  BSA, and 2/xCi of [32p]dCTP. 
Following elongation of the TS primer by telomerase, 
the mixture was incubated at 95°C for 5 min prior to 
addition of 5 units of Taq polymerase and 0.1 /xg of 
the CX primer (5'-CCCTTACCCTTACCCTTACC- 
CTAA-3'). The elongated products were amplified by 
PCR (27 cycles of 94°C for 30 s, 50°C for 30 s, and 
72°C for 60 s). Then, one-fourth of each reaction 
product was analyzed by electrophoresis in 1X Tris- 
borate EDTA on 15% polyacrylamide nondenaturing 
gels. The gels were fixed and exposed to X-ray film 
(Eastman Kodak Co., Rochester, NY) for an appro- 
priate length of time at -80°C with an intensifying 
screen. 
2.4. Quantitation of enzyme activity 
Enzyme activity was expressed in arbitrary units as 
total counts in the RNase-sensitive r action products, 
determined using NIH image software. In brief, the 
signal intensity of each band of the TRAP ladders 
was measured individually. These values were com- 
pared with TRAP products obtained with known 
amounts of control extract, assayed in parallel. The 
relative specific telomerase activity in each sample 
was expressed as a percentage of the specific activity 
of the control extracts. 
2.5. DNA isolation and Southern blot analysis 
High molecular weight DNA was extracted from 
PBMCs using proteinase K digestion, followed by 
phenol/chloroform extraction. Placental DNA was 
used instead of embryonal cells as a control for 
assessing the effect of cellular aging [9]. Five micro- 
262 O. Yamada et al. / Biochimica et Biophysica Acta 1314 (1996) 260-266 
grams of genomic DNA were digested with the re- 
striction endonuclease Hinfl (Takara Shuzou Co., 
Kyoto, Japan), according to the supplier's recommen- 
dations. The resulting fragments were fractionated by 
electrophoresis on0.8% agarose gels, and transferred 
to nylon membranes (Hybond N, Amersham Japan, 
Tokyo, Japan), after which hybridization was per- 
formed with a 32p-labeled telomere probe, as de- 
scribed previously [7]. The membranes were then 
exposed to X-ray film (Eastman Kodak Co., 
Rochester, NY) for an appropriate l ngth of time at 
-80°C with an intensifying screen. The lengths of 
telomeric repeats were measured with a computer- 
controlled laser beam densitometer (ACD-25DX; 
Atto, Tokyo, Japan). 
2.6. DNA clones 
The following DNA probes were used. The de- 
oxynucleotide polymer (TTAGGG) 7, usually 2 ng of 
a 42mer probe, was end-labeled with [32p]dCTP 
(Amersham Japan, Tokyo, Japan) using terminal de- 
oxynucleotidyl transferase in the recommended buffer 
(Bethesda Research Laboratories, Bethesda, MD). In 
some cases, the blots were rehybridized with a [32p]_ 
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Fig. 2. Telomerase activity in stimulated PBMCs from a normal 
donor. PBMCs were obtained before and after in vitro culture 
with PHA and IL-2, and 2 /xg of protein extract were assayed for 
telomerase. Telomerase activity was induced in the PBMCs 
within 24 h and continued to increase for 72 h. (Pre, before 
stimulation). 
end-labeled microsatellite probe 5'-(CAC)5-3', to con- 
firm that equal amounts of DNA had been loaded for 
each pair of samples [9]. 
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Fig. 1. Telomerase activity of four different peripheral blood cell 
fractions from a normal donor. Extracts obtained from T cells, B 
cells, monocytes, and polymorphonuclear leukocytes were used 
for TRAP assays (2 /xg protein per assay) with (+)  or without 
( - )  RNase pretreatment. Extracts from the telomerase-positive 
immortal cell line, U937, were used as controls (cont). The 
control assays contained 0.2 /xg and 0.02 /zg of protein. 
3.  Resu l t s  
3.1. Telomerase activity in different cell populations 
of normal blood cells 
Although most somatic ells lack telomerase activ- 
ity, some authors have reported telomerase activity in 
normal human blood cells [10]. Ficoll-isolated 
mononuclear cells contain several different ypes of 
cells. To determine whether different ypes of white 
blood cells have different telomerase activity, and 
therefore could influence the telomerase activity in 
peripheral blood cells, we compared telomerase activ- 
ity in T cells, B cells, monocytes, and polymorphonu- 
clear leukocytes from three normal volunteers. 
Telomerase activity was constitutively expressed in 
both the T cell and B cell fractions, but no activity 
was detected in either monocytes or polymorphonu- 
clear leukocytes (Fig. 1). Accordingly, the next study 
investigated whether or not telomerase activity could 
be induced in lymphocytes. 
O. Yamada et al. / Biochimica et Biophysica Acta 1314 (1996) 260-266 263 
I L -2  (U /ml )  102 102 10 ~ . . . .  10'  10~102MedPrePos i t i ve  
PHAX 10 -3 10 1 ½ 10 1 1~ control  
Posit ive 
ant i -CD3 Pre Med 0.01 0 .05 0 .25 contro l  
( / zg /ml )  , i ~ ~ ~ ~ 
RNase + - + - + - + - 
Fig. 3. Induction of telomerase activity after stimulation of 
PBMCs by PHA and/or IL-2. PBMCs from normal donors were 
cultured to induce telomerase activity in the presence of PHA, 
IL-2, or both for 72 h. Final concentrations are depicted at the top 
of the column. (Pre, before stimulation; Med, cultures with 
medium alone). 
3.2. Induction of  telomerase activity 
In order to examine tile inducibility of telomerase 
in lymphocytes, PBMCs from four different donors 
were cultured in the presence of PHA and/or  IL-2. 
Telomerase activity was examined prior to and fol- 
lowing stimulation. Telomerase was induced in the 
lymphocytes within 24 h of culture (Fig. 2). The 
induced telomerase actiivity continued to increase 
Fig. 4. Induction of telomerase activity in T lymphocytes stimu- 
lated with anti CD-3 mAb. PBMCs were cultured in the presence 
of the indicated amounts of anti CD-3 mAb for 48 h, and 
telomerase activity was measured by TRAP assay. (Pre, before 
stimulation; Med, cultures with medium alone). 
more than 10-fold over 96 h. During this time, the 
total number of cells remained constant, and more 
than 90% of the cells were viable. These results 
demonstrate that telomerase is regulated uring lym- 
phocyte activation, with enzyme activity increasing 
as cells progress to DNA synthesis prior to cell 
division. The contribution of PHA and IL-2 to telom- 
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Fig. 5. Induction of telomerase activity by LPS and SAC. PBMCs from normal donor were stimulated in vitro with each concentration f
LPS or SAC for 72 h. Cell lysates were assayed for telomerase activity by the TRAP method. (Pre, before stimulation; Med, cultures with 
medium alone). 
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erase induction was examined. IL-2 did not induce 
telomerase activity even at high concentrations, 
whereas PHA up-regulated telomerase activity (Fig. 
3). The anti-CD3 mAb, which specificially stimulates 
T lymphocytes, also induced telomerase activity over 
a wide range of concentrations (Fig. 4). Other mito- 
gens such as LPS and SAC were also examined. 
Telomerase was induced by culture for 3 days with 
SAC, a potent stimulator of B lymphocytes [1 1], at a 
level corresponding to that achieved by PHA stimula- 
tion, while LPS did not induce any telomerase activ- 
ity (Fig. 5). 
As immediate arly genes are induced in activated 
cells without any new protein synthesis, the induction 
of telomerase activity was examined in lymphocytes 
stimulated with PHA in the presence of CHX. Low 
level constitutive nzyme activity was seen in un- 
stimulated lymphocytes, and two-fold up-regulation 
occurred in the absence of ongoing protein synthesis 
(Fig. 6). Stimulation-induced telomerase activity was 
significantly higher in cells without CHX than in 
those pretreated with CHX. This demonstrates that 
CHX-sensitive gene products modulate telomerase 
activity in stimulated lymphocytes. 
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Fig. 7. Southern blot analysis of two normal donors whose DNA 
samples were available before and 3 days after stimulation of 
their PBMCs with PHA. DNA obtained from PBMCs before and 
after stimulation was digested with Hinf I and hybridized with a 
DNA probe to the telomere sequence. Pre and Post refer to 
samples obtained before and after stimulation, respectively. N1 
and N2 designate healthy volunteers in their 50s and 60s, respec- 
tively. A HindlII-digested lambda phage DNA size marker is 
indicated (kb). 
Fig. 6. Induction of telomerase activity after the stimulation of 
PBMCs from a normal donor by PHA in the presence (+) and 
absence ( - )  of CHX (10 /xg/ml). PBMCs were cultured for up 
to 72 h to induce telomerase activity. CHX was added 1 h before 
cell stimulation. Only the result of 48 h of stimulation are shown. 
Inhibition of protein synthesis reduced the induction of telom- 
erase level in stimulated cells. 
3.3. Telomeric DNA changes during induction of 
telomerase activity 
To determine whether telomeric DNA changes 
could be observed uring the induction of telomerase 
activity, we compared telomeric DNA in PBMCs 
obtained from the same volunteers prior to and fol- 
lowing stimulation. The telomeric DNA from the two 
normal donors was 9.0 and 8.2 kb prior to stimulation 
and 9.2 and 8.4 kb following stimulation (Fig. 7). 
4. Discussion 
The present study demonstrates that telomerase 
activity is present in PBMCs from normal donors, as 
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has been shown by others [10]. The telomerase activ- 
ity was low in all four donors, suggesting that en- 
zyme expression may be limited to a small subset of 
normal eukocytes. We separated the T cells, B cells, 
monocytes, and polymorphonuclear leukocytes from 
three of these normal donors, and compared the 
telomerase activity in these cell types. Telomerase 
activity was detected in the T cell and B cell frac- 
tions, but not in monocytes or polymorphonuclear 
leukocytes. These differences may arise from the 
differing proliferative capacities of the cells, as rest- 
ing lymphocytes can transform into lymphoblasts on 
exposure to either nonspecific mitogens or antigens. 
Alternatively some lymphocytes may already be 
stimulated in vivo. Cell life span and telomere length 
appear to be related, and many observations support 
the hypothesis that unlimited cell proliferation re- 
quires telomerase activity in order to overcome the 
potentially lethal loss of telomeric DNA, and to 
maintain functional telomeres [5]. 
Given the ability of LAK cells to proliferate for 
long periods in the presence of IL-2, as shown in our 
previous report [4], we speculated that the activation 
of telomerase by IL-2 in these cells may occur early, 
so the cells can continue to proliferate [5,6] by stabi- 
lizing telomere length through the addition of telom- 
eric repeats. We used both PHA and IL-2 to stimulate 
and maintain lymphocytes effectively. Telomerase 
was induced in activated lymphocytes from all the 
normal donors within 24 h. The activity increased 
gradually over 96 h. During these 96 h, the total cell 
count remained constant, suggesting that telomerase 
was induced concomitantly as the cells entered S 
phase upon stimulation with PHA. IL-2 is produced 
by activated T cells, and is important for the mainte- 
nance and proliferation of a number of cell types in 
the immune system, including T cells, B cells, natural 
killer cells, and lymphokine-activated killer cells. 
However, our study indicated that IL-2 was not cru- 
cial for the induction of telomerase activity, which 
disagreed with the findings of Hiyama et al. [12]. 
PHA is thought to bind to the T-cell receptor 
complex, and to activate T cells through T-cell recep- 
tor signal transduction. As is expected from our result 
that PHA caused telomerase induction, anti-CD3 
crosslinking also up-regulated telomerase activity. 
These results suggest that the induction of telomerase 
activity requires T-cell receptor-mediated signal 
transduction. LPS is a component of the cell mem- 
brane of Gram-negative bacteria, and stimulates the 
immune response by mainly activating monocytes/ 
macrophages [13]. The present study showed that 
LPS did not induce telomerase activity. On the other 
hand, SAC-activated B-cells demonstrated obvious 
telomerase induction during culture for 3 days. This 
early telomerase induction is different from that of B 
cells transformed by Epstein-Barr virus, because reac- 
tivation of telomerase by that virus occurs as a late 
event in the generation of immortal cells [14]. 
The inhibition of protein synthesis by CHX modi- 
fied the induction pattern of telomerase. The up-regu- 
lation of telomerase activity occurred in cells treated 
with CHX, but the level of activity was significantly 
less than that in cells not treated with CHX. The 
extended period over which telomerase is induced 
(48 h) suggests the activation of a secondary control 
mechanism. CHX-sensitive sensitive gene products 
may participate in modulating telomerase expression, 
and further analysis is necessary to elucidate the 
mechanisms of telomerase induction in activated 
lymphocytes. 
Telomeric DNA is lost every time somatic cells 
divide [15], presumably because of the inability of 
telomerase to fully replicate the ends of a linear DNA 
template. The calculated loss of telomeric DNA by 
the cultured cells is about 50 bp per population 
doubling for bone marrow cells and cord blood cells 
[ 16]. We did not detect he addition of tandem telom- 
eric repeats, (TTAGGG)n after the induction of 
telomerase activity in normal ymphocytes. In normal 
chromosome ends, telomere longation may be con- 
trolled even though telomerase is overexpressed, in 
order to maintain genomic stability. Alternatively, 
telomerase could add telomeric repeats only when 
cells divide, because cell numbers remained constant 
during the time we measured telomerase activity. To 
approach this question, long-term culture is neces- 
sary. Our present study presents a suitable system for 
the study of telomerase r gulation and for the testing 
of telomerase-inhibitory d ugs. 
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